BCTX (Briacell Therapeutics Corp. Common Shares) Stock Analysis - Community

Briacell Therapeutics Corp. Common Shares (BCTX) is a publicly traded Healthcare sector company. As of May 21, 2026, BCTX trades at $3.96 with a market cap of $24.29M and a P/E ratio of -0.06. BCTX moved +9.69% today. Year to date, BCTX is -49.28%; over the trailing twelve months it is -89.10%. Its 52-week range spans $2.98 to $214.50. Rallies surfaces BCTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade BCTX?

Rallies community data for BCTX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

BCTX Key Metrics

Key financial metrics for BCTX
MetricValue
Price$3.96
Market Cap$24.29M
P/E Ratio-0.06
EPS$-62.19
Dividend Yield0.00%
52-Week High$214.50
52-Week Low$2.98
Volume944
Avg Volume0
Revenue (TTM)$0
Net Income$-26.56M
Gross Margin0.00%

Latest BCTX News

Recent BCTX Insider Trades

  • Lustig Marc bought 902.93K (~$2.00M) on May 14, 2024.
  • Bondarenko Jamieson bought 28.00K (~$128.24K) on Dec 28, 2022.
  • Bondarenko Jamieson bought 22.00K (~$117.70K) on Dec 20, 2022.

BCTX Analyst Consensus

BCTX analyst coverage data. Average price target: $0.00.

Common questions about BCTX

How does the Rallies community trade BCTX?
Rallies community data for BCTX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for BCTX?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for BCTX when enough community data is available.
Is BCTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BCTX. It does not provide personalized investment advice.
BCTX

BCTX